Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Technology Update

28 Nov 2018 07:00

RNS Number : 6896I
Plant Health Care PLC
28 November 2018
 

28 November 2018

 

PLANT HEALTH CARE plc

 

 

("Plant Health Care" or the "Company")

 

 

New Technology Update 

 

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update in relation to its New Technology business in corn and soy crops.

 

Highlights:

- Plant Health Care's novel PREtec (Plant Response Elicitor Technology) has very large potential in the more than 375 million acres of corn and soy planted in North America, Brazil and Argentina.

- Three more global agricultural/seed companies have signed agreements to evaluate Plant Health Care's PREtec product candidates on multiple crops on three continents.

- These new collaborators are seeking novel, low toxicity biological products such as PREtec, to enable farmers to be more productive with lower environmental impact.

- Plant Health Care is continuing field trials with the Company's Innatus 3G peptide PHC279 against Asian Soybean Rust (ASR) in Brazil.

 

PREtec is a novel, environmentally friendly approach to protecting crops, based on peptides derived from natural proteins. These proprietary peptides are stable and compatible with mainstream agriculture practices. By activating the innate growth and defence mechanisms of plants, PREtec peptides lead to higher crop yields and better protection against disease and environmental stresses such as drought.

 

Corn and soy are major targets for PREtec. They are grown on more than 375 million acres in North and South America. A yield increase of just 2% brings a soybean farmer in Brazil almost an additional $10 per acre; in the USA it brings a corn (maize) farmer almost $13 per acre. Plant Health Care's evaluation partners supply most of the leading corn and soy seed treatments.

 

PREtec peptides can also reduce the corn yield losses caused by drought stress during critical growth stages. Under the drought conditions of the Company's field trials, corn plants whose seeds were treated with PREtec increased yield by an average of almost 17% over three consecutive growing seasons compared to untreated plants.

 

Three additional global agricultural companies have now signed agreements to evaluate several platforms of the PREtec technology. These companies join existing evaluation partners, who are looking for novel technology that will boost yield in row crops and have a safe environmental profile while solving significant problems faced by growers today.

 

In the 2018/19 soybean growing season in Brazil, Plant Health Care will be conducting further trials of PHC279 against Asian Soybean Rust (ASR). Last season this product did not deliver a decisive impact on disease symptoms as a foliar spray, but did show yield improvements. This season, trials will assess the economic value of PHC279 seed treatment and early season sprays.

 

Chris Richards, Executive Chairman & Interim CEO, said "As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our range of partners who will evaluate our technology on multiple crops in multiple regions during the 2019 growing season."

 

For further information, please contact:

 

Plant Health Care plc

 

Chris Richards, Executive Chairman and Interim CEO

 

Tel: +1 919 926 1600

Arden Partners plc (Nomad and Broker)

John Llewellyn-Lloyd

 

Dan Gee-Summons

Tel: +44 (0) 20 7614 5900

 

IFC Advisory (Financial PR)

 

Graham Herring

 

Miles Nolan

 

Zach Cohen

Tel: +44 (0) 20 3934 6630

 

 

 

Company website: www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPGGCGGUPRGBM
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.